EXCELINDUS
Excel Industries Limited
Specialty and commodity chemicals manufacturer
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
excelind.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Excel Industries (Excel) is a chemicals maker whose core strength is phosphorus chemistry, selling agrochemical intermediates, phosphonates (used in water treatment, soaps and detergents, industrial and institutional cleaners and textile auxiliaries), biocides and other specialty chemicals, and also manufacturing under contract for other companies.
Company snapshot
41stBy market cap
Ranked among 68 companies in Specialty Chemicals.
Segment mix
Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.
Largest segment: 99.1% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Chemicals | 99.1% | 195 Cr | 21 Cr | 751 Cr |
| Environment and Biotech | 0.9% | 2 Cr | -2 Cr | 17 Cr |
What we see
- ✓Debt-to-equity of 0.00x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 198 Cr | 180 Cr | 234 Cr | 265 Cr | 269 Cr | 196 Cr | 248 Cr | 310 Cr | 270 Cr | 234 Cr | 281 Cr | 294 Cr |
| Operating expenses (approx.) | 195 Cr | 179 Cr | 221 Cr | 226 Cr | 220 Cr | 184 Cr | 228 Cr | 267 Cr | 240 Cr | 218 Cr | 259 Cr | 251 Cr |
| EBITDA | 3 Cr | 2 Cr | 12 Cr | 39 Cr | 49 Cr | 12 Cr | 20 Cr | 42 Cr | 30 Cr | 16 Cr | 22 Cr | 42 Cr |
| OPM % | 1.3% | 0.9% | 5.2% | 14.7% | 18.2% | 6.1% | 7.9% | 13.6% | 11.1% | 6.7% | 7.8% | 14.4% |
| Other income | 7 Cr | 11 Cr | 5 Cr | 11 Cr | 8 Cr | 5 Cr | 6 Cr | 12 Cr | 7 Cr | 5 Cr | 3 Cr | 7 Cr |
| Interest | 0.26 Cr | 0.74 Cr | 0.29 Cr | 0.61 Cr | 1 Cr | 0.28 Cr | 0.26 Cr | 1 Cr | 0.75 Cr | 0.45 Cr | 0.25 Cr | 0.59 Cr |
| Depreciation | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 10 Cr | 10 Cr |
| Profit before tax | 2 Cr | 4 Cr | 9 Cr | 41 Cr | 47 Cr | 8 Cr | 16 Cr | 44 Cr | 27 Cr | 11 Cr | 15 Cr | 39 Cr |
| Tax % | 8.6% | 34.6% | 25.0% | 24.6% | 24.3% | 26.2% | 23.8% | 24.1% | 22.9% | 24.8% | 16.2% | 24.3% |
| Net profit | 2 Cr | 3 Cr | 7 Cr | 31 Cr | 36 Cr | 6 Cr | 12 Cr | 34 Cr | 21 Cr | 8 Cr | 12 Cr | 29 Cr |
| EPS (₹) | ₹1.42 | ₹2.13 | ₹5.31 | ₹24.68 | ₹28.39 | ₹4.93 | ₹9.87 | ₹26.86 | ₹16.85 | ₹6.71 | ₹9.77 | ₹23.44 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 504 Cr | 611 Cr | 825 Cr | 702 Cr | 749 Cr | 1,178 Cr | 1,090 Cr | 826 Cr | 978 Cr | 1,095 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 462 Cr | 488 Cr | 576 Cr | 573 Cr | 629 Cr | 948 Cr | 963 Cr | 803 Cr | 859 Cr | 985 Cr | Sign in free for the trailing twelve months |
| EBITDA | 42 Cr | 123 Cr | 249 Cr | 129 Cr | 121 Cr | 230 Cr | 126 Cr | 23 Cr | 120 Cr | 110 Cr | Sign in free for the trailing twelve months |
| OPM % | 8.3% | 20.1% | 30.2% | 18.4% | 16.1% | 19.6% | 11.6% | 2.8% | 12.2% | 10.0% | Sign in free for the trailing twelve months |
| Other income | 10 Cr | 5 Cr | 6 Cr | 11 Cr | 9 Cr | 16 Cr | 13 Cr | 33 Cr | 30 Cr | 27 Cr | Sign in free for the trailing twelve months |
| Interest | 10 Cr | 6 Cr | 2 Cr | 3 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Depreciation | 14 Cr | 15 Cr | 18 Cr | 23 Cr | 27 Cr | 31 Cr | 31 Cr | 31 Cr | 34 Cr | 37 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 27 Cr | 107 Cr | 234 Cr | 115 Cr | 101 Cr | 213 Cr | 106 Cr | 23 Cr | 113 Cr | 98 Cr | Sign in free for the trailing twelve months |
| Tax % | 25.6% | 30.9% | 34.5% | 16.4% | 29.5% | 24.5% | 24.4% | 24.9% | 24.5% | 22.6% | Sign in free for the trailing twelve months |
| Net profit | 20 Cr | 74 Cr | 153 Cr | 96 Cr | 71 Cr | 161 Cr | 80 Cr | 17 Cr | 85 Cr | 76 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹15.88 | ₹58.78 | ₹122.07 | ₹76.43 | ₹56.55 | ₹128.24 | ₹63.59 | ₹5.31 | ₹67.87 | ₹60.19 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 0.0% | 8.8% | 35.3% | 83.4% | 8.1% | 22.8% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr |
| Reserves | 404 Cr | 526 Cr | 693 Cr | 695 Cr | 845 Cr | 1,143 Cr | 1,235 Cr | 1,421 Cr | 1,582 Cr | 1,697 Cr |
| Borrowings | 60 Cr | 8 Cr | 6 Cr | 21 Cr | 9 Cr | 5 Cr | 0.89 Cr | — | 0.05 Cr | 0.09 Cr |
| Other liabilities | 149 Cr | 188 Cr | 210 Cr | 215 Cr | 251 Cr | 332 Cr | 250 Cr | 368 Cr | 332 Cr | 402 Cr |
| Total liabilities | 619 Cr | 728 Cr | 916 Cr | 937 Cr | 1,111 Cr | 1,487 Cr | 1,493 Cr | 1,796 Cr | 1,920 Cr | 2,105 Cr |
| Fixed assets (net) | 182 Cr | 202 Cr | 237 Cr | 332 Cr | 369 Cr | 407 Cr | 408 Cr | 408 Cr | 423 Cr | 438 Cr |
| CWIP | 8 Cr | 23 Cr | 12 Cr | 9 Cr | 17 Cr | 21 Cr | 19 Cr | 18 Cr | 8 Cr | 38 Cr |
| Investments | 211 Cr | 282 Cr | 395 Cr | 266 Cr | 366 Cr | 547 Cr | 625 Cr | 962 Cr | 1,100 Cr | 1,141 Cr |
| Loans & advances | — | — | 4 Cr | 2 Cr | 2 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 0.24 Cr |
| Inventories | 55 Cr | 56 Cr | 69 Cr | 78 Cr | 69 Cr | 165 Cr | 131 Cr | 106 Cr | 94 Cr | 129 Cr |
| Trade receivables | 120 Cr | 125 Cr | 158 Cr | 150 Cr | 173 Cr | 199 Cr | 157 Cr | 185 Cr | 216 Cr | 261 Cr |
| Cash & bank | 3 Cr | 4 Cr | 4 Cr | 21 Cr | 42 Cr | 30 Cr | 4 Cr | 8 Cr | 12 Cr | 13 Cr |
| Other assets | 39 Cr | 37 Cr | 37 Cr | 80 Cr | 73 Cr | 115 Cr | 147 Cr | 107 Cr | 65 Cr | 85 Cr |
| Total assets | 619 Cr | 728 Cr | 916 Cr | 937 Cr | 1,111 Cr | 1,487 Cr | 1,493 Cr | 1,796 Cr | 1,920 Cr | 2,105 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 31 Cr | 119 Cr | 135 Cr | 110 Cr | 91 Cr | 109 Cr | 125 Cr | 72 Cr | 62 Cr | 53 Cr |
| Cash from investing | 16 Cr | -45 Cr | -111 Cr | -61 Cr | -53 Cr | -104 Cr | -118 Cr | -51 Cr | -41 Cr | -25 Cr |
| Cash from financing | -48 Cr | -73 Cr | -24 Cr | -31 Cr | -17 Cr | -17 Cr | -35 Cr | -17 Cr | -16 Cr | -27 Cr |
| Net cash flow | -0.90 Cr | 0.79 Cr | -0.45 Cr | 17 Cr | 21 Cr | -12 Cr | -27 Cr | 4 Cr | 4 Cr | 0.84 Cr |
| Free cash flow (OCF − Capex) | -6 Cr | 67 Cr | 89 Cr | 44 Cr | 43 Cr | 35 Cr | 93 Cr | 40 Cr | 18 Cr | -27 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 7.9% | 20.9% | 33.5% | 16.3% | 12.0% | 18.7% | 8.7% | 1.7% | 7.3% | 5.9% |
| ROE % | 4.9% | 13.9% | 21.9% | 13.7% | 8.3% | 14.0% | 6.4% | 1.2% | 5.4% | 4.4% |
| Debtor days | 87 | 74 | 70 | 78 | 84 | 62 | 52 | 82 | 80 | 87 |
| Inventory days | 89 | 75 | 71 | 86 | 70 | 97 | 78 | 80 | 66 | 78 |
| Days payable | 101 | 118 | 103 | 116 | 125 | 106 | 63 | 139 | 96 | 91 |
| Cash conversion cycle | 75 | 32 | 38 | 48 | 29 | 53 | 67 | 22 | 50 | 74 |
| OCF / EBITDA % | 74.1% | 97.1% | 54.3% | 85.1% | 75.3% | 47.3% | 99.1% | n.m. | 51.7% | 48.2% |
| OCF / EBITDA % (3 years) | — | — | 69.0% | 72.7% | 67.4% | 64.5% | 68.1% | 80.7% | 96.5% | 74.1% |
| Debt / equity | 0.15 | 0.01 | 0.0089 | 0.03 | 0.01 | 0.0046 | 0.0007 | — | 0.0000 | 0.0001 |
| Current ratio | 1.50 | 1.87 | 2.91 | 1.99 | 2.21 | 2.45 | 3.79 | 2.70 | 3.19 | 2.49 |
| Net debt / EBITDA | 1.35 | — | 0.01 | 0.0028 | -0.28 | -0.11 | -0.02 | -0.34 | -0.10 | -0.12 |